Compare CAN & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAN | BVS |
|---|---|---|
| Founded | 2013 | 2011 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 486.0M | 482.9M |
| IPO Year | 2019 | 2016 |
| Metric | CAN | BVS |
|---|---|---|
| Price | $0.50 | $8.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | $3.09 | ★ $13.33 |
| AVG Volume (30 Days) | ★ 12.1M | 285.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.33 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | N/A | $7.42 |
| Revenue Next Year | $63.64 | $6.46 |
| P/E Ratio | ★ N/A | $27.65 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.43 | $5.81 |
| 52 Week High | $2.22 | $11.25 |
| Indicator | CAN | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 41.69 | 50.32 |
| Support Level | $0.43 | $6.42 |
| Resistance Level | $0.80 | $9.01 |
| Average True Range (ATR) | 0.04 | 0.38 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 47.27 | 18.94 |
Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.